COMPANY
Cardinal Health Inc.
Cardinal Health Inc.: recalling firm for Dulaglutide, Linaclotide, Semaglutide, as stated by public registers.
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Dulaglutide | Class II recall, Completed, 2022-05-25 Regulator openFDA |
|---|---|
| Linaclotide | Class II recall, Terminated, 2021-06-02 Regulator openFDA |
| Semaglutide | Class II recall, Ongoing, 2025-05-07 Regulator openFDA |
| Semaglutide | Class II recall, Terminated, 2021-06-02 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.